Full coverage
The White House withdrew Heidi Overton’s nomination to lead the FDA ahead of a scheduled Senate committee vote.
The White House said Overton lacked enough congressional support to advance her confirmation. Several outlets reported that the Senate health committee had planned to vote on her nomination Wednesday.
What the reports agree on
- The White House withdrew Overton’s nomination to lead the FDA. Axios, The Hill, ABC News, CBS News and 1 more
- The Senate health committee had scheduled a vote on her nomination for Wednesday. Axios, The Hill, CBS News
- Republican senators had raised concerns or doubts about Overton’s nomination. Axios, The Hill, ABC News, Guardian World
Where reports differ
- The Hill reported that Republicans held a one-vote majority on the Senate health committee. The Hill
- Guardian World reported that Overton needed all 12 committee Republicans to support her nomination to advance, while Democrats held 11 seats. Guardian World
Reported by one outlet
- The White House said Overton did not have enough support in Congress to advance her confirmation. Axios
- Overton faced Republican concerns about her positions on abortion, vaccines and vaping. ABC News
- Administration officials confirmed the withdrawal. CBS News
- Overton wrote in a 2023 policy brief that Congress should strictly regulate mifepristone. Guardian World
The original reports
- The Hill Cassidy questions ‘odd’ White House move in pulling FDA nominee
- Guardian World White House withdraws nomination of Heidi Overton to lead FDA
- CBS News White House drops Heidi Overton's nomination for FDA commissioner
- The Hill White House pulls nomination of Heidi Overton to lead FDA
- ABC News Trump's pick Heidi Overton dropped as nominee for FDA commissioner
- Axios Scoop: White House drops Heidi Overton's FDA nomination
- CBS News Trump FDA nominee Heidi Overton struggling to win GOP support